Breaking News

Close

Genmab AS (GMAB)

	Symbol	Exchange	Currency
	GMAB	NASDAQ	USD	Real-time
	GMABc	BATS Europe	DKK	Delayed
	0MGB	London	DKK	Real-time
	GMAB	Copenhagen	DKK	Real-time
	GMAB	Vienna	EUR	Real-time

Add to/Remove from Watchlist Add to Watchlist

28.84 +0.03 +0.10%

10/05 - Closed. Currency in USD ( Disclaimer )

After Hours

28.84

-0.00

-0.00%

16:00:19 - Real-time Data

Type: Equity

Market: United States

Volume: 259,970
Bid/Ask: 0.00 / 0.00
Day's Range: 28.71 - 28.93

GMAB Candlestick Patterns

Dozens of bullish and bearish live candlestick chart patterns for the Genmab AS stock and use them to predict future market behavior. The Genmab AS stock patterns are available in a variety of time frames for both long and short term investments. Gain a trading edge with the auto pattern recognition feature and gain an insight into what the patterns mean.

Candlestick Chart

1
5
15
30
1H
5H
1D
1W
1M

Loading

Last Update:

1 Day
1 Week
1 Month
3 Months
6 Months
1 Year
5 years
Max

Candlestick Patterns

Pattern		Timeframe	Reliability	Candles Ago	Candle Time
Emerging Patterns
	Harami Bearish	30		Current
Completed Patterns
	Harami Cross	1M		3	Feb 24
	Belt Hold Bullish	5H		3	May 09, 2024 08:00AM
	Separating Lines Bullish	1H		5	May 10, 2024 11:00AM
	Doji Star Bearish	5H		6	May 07, 2024 04:00PM
	Bullish doji Star	1H		6	May 10, 2024 10:00AM
	Three Inside Up	1H		11	May 09, 2024 01:00PM
	Bullish doji Star	30		12	May 10, 2024 10:00AM
	Morning Star	1M		13	Apr 23
	Dragonfly Doji	1M		14	Mar 23
	Bullish doji Star	1W		14	Jan 28, 2024
	Three Black Crows	5H		14	May 02, 2024 11:00AM
	Three Outside Up	1H		14	May 09, 2024 10:00AM
	Three Black Crows	1M		15	Feb 23
	Three Black Crows	1W		15	Jan 21, 2024
	Belt Hold Bullish	1H		15	May 09, 2024 09:00AM
	Bullish Engulfing	1H		15	May 09, 2024 09:00AM
	Three Inside Up	1H		15	May 09, 2024 09:00AM
	Harami Bullish	1H		16	May 08, 2024 04:00PM
	Harami Cross	1H		16	May 08, 2024 04:00PM
	Three Inside Down	30		17	May 09, 2024 02:30PM
	Three Inside Up	1W		19	Dec 24, 2023
	Bullish Hammer	1H		19	May 08, 2024 01:00PM
	Inverted Hammer	5H		20	Apr 30, 2024 09:00AM
	Thrusting Bearish	1W		23	Nov 26, 2023
	Falling Three Methods	1M		24	May 22
	Engulfing Bearish	15		26	May 10, 2024 09:30AM
	Belt Hold Bearish	15		26	May 10, 2024 09:30AM
	Belt Hold Bullish	30		27	May 09, 2024 09:30AM
	Bullish Engulfing	30		27	May 09, 2024 09:30AM
	Harami Bullish	1M		29	Dec 21
	Three Outside Up	30		32	May 08, 2024 02:00PM
	Bullish Engulfing	30		33	May 08, 2024 01:30PM
	Harami Bearish	5H		34	Apr 19, 2024 01:00PM
	Doji Star Bearish	1M		35	Jun 21
	Engulfing Bearish	1W		35	Sep 03, 2023
	Inverted Hammer	30		35	May 08, 2024 12:30PM
	Three Inside Up	1H		36	May 06, 2024 12:00PM
	Bullish Engulfing	1M		37	Apr 21
	Harami Bullish	1H		37	May 06, 2024 11:00AM
	Three Black Crows	1M		38	Mar 21
	Three Black Crows	1D		39	Mar 15, 2024
	Harami Cross Bearish	1H		40	May 03, 2024 04:00PM
	Three Outside Up	30		43	May 07, 2024 03:30PM
	Bullish Engulfing	30		44	May 07, 2024 03:00PM
	Bullish Hammer	1W		45	Jun 25, 2023
	Engulfing Bearish	1H		46	May 03, 2024 10:00AM
	Three Outside Up	15		47	May 09, 2024 11:00AM
	Three Outside Up	1M		48	May 20
	Bullish Engulfing	15		48	May 09, 2024 10:45AM
	Bullish Engulfing	1M		49	Apr 20
	Homing Pigeon	1D		50	Feb 29, 2024
	Harami Bearish	5H		50	Apr 10, 2024 02:00PM
	Belt Hold Bearish	30		51	May 07, 2024 11:30AM
	Three Outside Up	15		52	May 09, 2024 09:45AM
	Shooting Star	15		52	May 09, 2024 09:45AM
	Inverted Hammer	15		52	May 09, 2024 09:45AM
	Three Black Crows	1H		53	May 02, 2024 10:00AM
	Belt Hold Bullish	15		53	May 09, 2024 09:30AM
	Bullish Engulfing	15		53	May 09, 2024 09:30AM
	Three Black Crows	5H		57	Apr 05, 2024 09:00AM
	Belt Hold Bullish	15		57	May 08, 2024 03:15PM
	Falling Three Methods	1W		62	Feb 26, 2023
	Falling Three Methods	1W		63	Feb 19, 2023
	Three Inside Up	1W		64	Feb 12, 2023
	Deliberation Bearish	5H		64	Apr 01, 2024 03:00PM
	Bullish Engulfing	15		64	May 08, 2024 01:30PM
	Harami Bullish	1W		65	Feb 05, 2023
	Harami Cross	1W		65	Feb 05, 2023
	Bullish Engulfing	5H		66	Apr 01, 2024 05:00AM
	Dragonfly Doji	1W		68	Jan 15, 2023
	Harami Cross	1W		68	Jan 15, 2023

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

GMAB Comments

Write your thoughts about Genmab AS

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

klepid Nov 10, 2021 11:45AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

ERs are out https://ir.genmab.com/financial-calendar

0 0

Jens Jensen Aug 11, 2021 3:39PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

And no debt, $3B cash position, one of the most "trending" technologies around (bispecific antibodies) and an impressive outflux of new drugs via seemingly peerpoor (now that's a nice new word - you're free to use it;-) quality of research. I urge everyone to check it out - heres the Investor Presentation for Q22021 "https://ir.genmab.com/static-files/cac2e584-6554-4637-a367-a5d21abc51e0". Comp value 2day $30B, best realistic ;-) guess is double up in 3-4 yrs. Seriously.

0 0

Jens Jensen Aug 11, 2021 3:14PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Falling.. standard market reaction these days to good and solid reportings: crazy that is.. in spite of improved revenue outlook, 4 drugs on market (darazalex(need I say more?)+3 soon-to-become-blockbusters) + 1 prob-to-market-in-october (tisotumab vedotin, w Seagen) + 2 new drugs revealed (one of which: inclacumab - a Sickle Cell Disease treatment, outlicensed to Roche and further outlicensed to Global Blood Therapeutics, but none the less - w potential for BB).

0 0

JohnJenga Mar 10, 2021 8:45AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

32, 40 again soon

0 0

Morten Lyng May 28, 2020 4:18PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Luxus

0 0

Morten Lyng May 26, 2020 6:01PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Going 200 % up in the next 24-30 month

4 0

Mirko Prazzoli May 12, 2020 12:45PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

what about this stock?

0 0

Morten Lyng May 02, 2020 3:32AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

The best upcoming medico company for cancer

4 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="201608058">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="201608058" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="201608058" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="201608058">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	39,487.2	+99.4	+0.25%
	US 500	5,218.1	+4.0	+0.08%
	Dow Jones	39,512.84	+125.08	+0.32%
	S&P 500	5,222.68	+8.60	+0.16%
	Nasdaq	16,340.87	-5.40	-0.03%
	S&P 500 VIX	12.55	0.00	0.00%
	Dollar Index	105.175	+0.071	+0.07%

	Crude Oil WTI	78.20	-1.06	-1.34%
	Brent Oil	82.78	-1.10	-1.31%
	Natural Gas	2.252	-0.049	-2.13%
	Gold	2,366.90	+26.60	+1.14%
	Silver	28.395	+0.030	+0.11%
	Copper	4.6520	+0.0670	+1.46%
	US Soybeans	1,218.75	+10.75	+0.89%

	U.S. 10Y	4.500	-0.004	-0.08%
	U.S. 30Y	4.642	+-0.004	+-0.08%
	U.S. 5Y	4.516	+-0.002	+-0.04%
	U.S. 3M	5.406	+0.015	+0.28%
	US 10Y T-Note	108.72	-0.38	-0.34%
	Euro Bund	130.88	-0.14	-0.11%
	10-2 Yield Spread	-34.29	+2.85	+-7.67%

	Apple	183.05	-1.27	-0.69%
	Alphabet A	168.65	-1.31	-0.77%
	Tesla	168.47	-3.50	-2.04%
	Amazon.com	187.48	-2.02	-1.07%
	Netflix	610.87	-1.22	-0.20%
	Meta Platforms	476.20	+0.78	+0.16%
	Bank of America	38.45	+0.17	+0.43%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GMAB	28.84	+0.03	+0.10%

	Name	Last	Chg. %	Vol.
	TSLA	168.47	-2.04%	71.53M
	AAPL	183.05	-0.69%	40.34M
	AMD	151.92	-0.31%	37.43M
	AMZN	187.48	-1.07%	34.07M
	NVDA	898.78	+1.27%	33.22M
	MSFT	414.74	+0.59%	12.66M
	BRKa	621,170	+0.87%	14.00K

	Name	Last	Chg. %	Vol.
	MTD	1,513.03	+17.25%	425.09K
	GEN	23.46	+15.34%	13.62M
	ANET	314.10	+6.09%	5.16M
	CHTR	275.55	+4.40%	1.77M
	WAT	350.78	+4.27%	710.53K
	FICO	1,330.02	+3.36%	424.53K
	CBRE	90.23	+3.19%	1.61M

	Name	Last	Chg. %	Vol.
	AKAM	91.19	-11.00%	9.72M
	PODD	165.90	-6.55%	3.16M
	MRNA	117.31	-4.39%	4.23M
	IP	38.58	-3.16%	6.28M
	ALGN	271.70	-3.10%	729.75K
	CZR	36.18	-3.00%	5.22M
	ALB	129.60	-2.96%	1.87M